However, lamivudine is also used in the treatment of hepatitis B. Whether or not OCT1 polymorphisms might predict therapeutic efficacy of lamivudine against hepatitis B might be an interesting research topic. The gene discussed is SLC22A1; the disease is hepatitis B virus infection.